We are live on ! Find out more
TMCI icon

Treace Medical Concepts
TMCI

118 hedge funds and large institutions have $48.3M invested in Treace Medical Concepts in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 28 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

25% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 28

3% more funds holding

Funds holding: 115 → 118 (+3)

0.45% less ownership

Funds ownership: 56.17% → 55.72% (-0.45%)

45% less capital invested

Capital invested by funds: $87.8M → $48.3M (-$39.5M)

Holders
118
Holders Change
+3
Holders Change %
+2.61%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
35
Reduced
28
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GS
Gagnon Securities
New York
+$4.17M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$2.12M
3
Bank of America
Bank of America
North Carolina
+$1.79M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.22M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.04M

Top Sellers

1
GA
Gagnon Advisors
New York
-$3.76M
2
First Eagle Investment Management
First Eagle Investment Management
New York
-$3.58M
3
William Blair Investment Management
William Blair Investment Management
Illinois
-$2.81M
4
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services
Minnesota
-$708K
5
Millennium Management
Millennium Management
New York
-$707K
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
126
Point72 Asset Management
Connecticut
– -$416K -169,792 Closed
JF
127
Jump Financial
Illinois
– -$380K -154,946 Closed
AC
128
Aristides Capital
Kentucky
– -$173K -70,500 Closed
SSA
129
Schonfeld Strategic Advisors
New York
– -$154K -62,674 Closed
HF
130
HRT Financial
New York
– -$149K -61,210 Closed
PHS
131
PFM Health Sciences
California
– -$123K -50,000 Closed
Simplex Trading
132
Simplex Trading
Illinois
– -$51.7K -25,929 Closed
Verition Fund Management
133
Verition Fund Management
Connecticut
– -$53.8K -21,973 Closed
A
134
AlphaQuest
New York
– -$49.6K -20,250 Closed
SG Americas Securities
135
SG Americas Securities
New York
– -$46K -18,751 Closed
BW
136
Balance Wealth
Ohio
– -$37.2K -15,203 Closed
Prudential Financial
137
Prudential Financial
New Jersey
– -$30.1K -12,290 Closed
GCM
138
Graham Capital Management
Connecticut
– -$27K -11,007 Closed
AB
139
Amalgamated Bank
New York
– -$4K -1,498 Closed
QCG
140
Quadrant Capital Group
Ohio
– -$1.69K -688 Closed
Los Angeles Capital Management
141
Los Angeles Capital Management
California
– -$1.38K -218 Closed
AAP
142
Arax Advisory Partners
Colorado
– -$42 -17 Closed
C
143
Covestor
United Kingdom
– +$48 +24 +240%
2 3 4 5
6

TMCI Hedge Fund Activity: Q1 2026 in Review

118 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2026, worth a combined $48.3M — down 45% from $87.8M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new TMCI positions and 25 closed out — a net gain of 7 holders — while 35 added to existing stakes and 28 trimmed.

The largest buyer was Gagnon Securities, adding an estimated $4.17M. The largest seller was Gagnon Advisors, exiting entirely with an estimated $3.76M sold.

  • 118 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2026, up from 115 in Q4 2025.
  • Funds reported $48.3M of Treace Medical Concepts stock for Q1 2026, down 45% quarter-over-quarter.
  • 32 funds opened new Treace Medical Concepts positions in Q1 2026 and 25 closed out, a net change of +7 holders.
  • The largest Treace Medical Concepts buyer in Q1 2026 was Gagnon Securities, an estimated $4.17M added.
  • The largest Treace Medical Concepts seller in Q1 2026 was Gagnon Advisors, an estimated $3.76M sold.

Based on aggregated 13F filings for Q1 2026.